California State Teachers Retirement System Humanigen, Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.76 - $3.33 $120,943 - $228,830
-68,718 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.81 - $3.97 $2,821 - $6,189
1,559 Added 2.32%
68,718 $207,000
Q4 2021

Feb 15, 2022
BUY
$3.66 - $8.22 $60,331 - $135,498
16,484 Added 32.53%
67,159 $250,000
Q3 2021

Nov 15, 2021
SELL
$5.93 - $17.83 $66,279 - $199,285
-11,177 Reduced 18.07%
50,675 $301,000
Q2 2021

Aug 16, 2021
BUY
$13.54 - $22.74 $837,476 - $1.41 Million
61,852 New
61,852 $1.08 Million

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email